CircKat6b Mediates the Antidepressant Effect of Esketamine by Regulating Astrocyte Function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CircKat6b Mediates the Antidepressant Effect of Esketamine by Regulating Astrocyte Function

Published:2024-08-14 Issue: Volume: Page:
ISSN:0893-7648
Container-title:Molecular Neurobiology
language:en
Short-container-title:Mol Neurobiol

Author:

Hu Na,Zheng Yujie,Liu Xueru,Jia Jing,Feng Jianguo,Zhang Chunxiang,Liu Li,Wang Xiaobin

Funder

Department of Science and Technology of Sichuan Province

Scientific research project of Luzhou Science and Technology Bureau

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12035-024-04420-0.pdf

Reference52 articles.

1. Charlson F, van Ommeren M, Flaxman A, Cornett J, Whiteford H, Saxena S (2019) New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis. Lancet (London, England) 394(10194):240–248. https://doi.org/10.1016/s0140-6736(19)30934-1

2. Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science (New York, NY) 338(6103):68–72. https://doi.org/10.1126/science.1222939

3. McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S et al (2021) Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry 178(5):383–399. https://doi.org/10.1176/appi.ajp.2020.20081251

4. Kim J, Farchione T, Potter A, Chen Q, Temple R (2019) Esketamine for treatment-resistant depression - first FDA-approved antidepressant in a new class. N Engl J Med 381(1):1–4. https://doi.org/10.1056/NEJMp1903305

5. Singh JB, Fedgchin M, Daly E, Xi L, Melman C, De Bruecker G, Tadic A, Sienaert P et al (2016) Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study. Biol Psychiatry 80(6):424–431. https://doi.org/10.1016/j.biopsych.2015.10.018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3